Severe Hypoxemia-associated Intrapulmonary Shunt in a Patient with Chronic Liver Disease: Improvement After Medical Treatment
Overview
Affiliations
A 20-yr-old woman with chronic liver disease and angioimmunoblastic lymphadenopathy presented with marked hypoxemia caused by intrapulmonary shunt. Her respiratory tract showed her to be free of angioimmunoblastic lymphadenopathy manifestations. After 12 months of treatment with cyclophosphamide and corticosteroid, the immunologic disease disappeared. Unexpectedly, hypoxia-associated intrapulmonary shunt was no longer present either. To the best of our knowledge, this is the first case of dramatic improvement, with medical therapy, of severe hypoxemia related to noncirrhotic liver disease. However, the mechanism by which this treatment caused the regression of intrapulmonary shunt is unknown.
Hepatopulmonary syndrome: What we know and what we would like to know.
Grilo-Bensusan I, Pascasio-Acevedo J World J Gastroenterol. 2016; 22(25):5728-41.
PMID: 27433086 PMC: 4932208. DOI: 10.3748/wjg.v22.i25.5728.
Current concepts in the management of hepatopulmonary syndrome.
Ho V Vasc Health Risk Manag. 2009; 4(5):1035-41.
PMID: 19183751 PMC: 2605324. DOI: 10.2147/vhrm.s3608.
Saunders K, Fernando S, Dalton H, Joseph A Thorax. 1994; 49(7):725-7.
PMID: 8066574 PMC: 475070. DOI: 10.1136/thx.49.7.725.
Intrapulmonary shunts: coils to transplantation.
Hughes J J R Coll Physicians Lond. 1994; 28(3):247-53.
PMID: 7932323 PMC: 5400969.
Stoller J, Lange P, Westveer M, Carey W, Vogt D, Henderson J West J Med. 1995; 163(2):133-8.
PMID: 7571560 PMC: 1303007.